Although an increase in muscle strength is not systematically observed in response to the pharmacological inhibition of myostatin37, a number of studies have clearly described an increase in muscle strength following an anti-myostatin treatement in experimental model of muscle wasting, including mdx Duchenne muscular dystrophy mice21,38, mouse model of cancer cachexia11,17, or mice aging20. Here, MSTN is linked to muscular dystrophy.